Alexander Nowak
Stock Analyst at Craig-Hallum
(4.46)
# 345
Out of 4,732 analysts
48
Total ratings
55.56%
Success rate
21.86%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $17.62 | +24.86% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $158.36 | -0.86% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $10.04 | +69.32% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $41.74 | +36.56% | 6 | Sep 5, 2024 | |
| CELC Celcuity | Assumes: Buy | $25 → $27 | $10.93 | +147.03% | 2 | May 16, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $21.44 | -30.04% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $5.71 | +40.11% | 4 | Apr 24, 2024 | |
| AXDX Accelerate Diagnostics | Maintains: Hold | $2 → $1 | $1.07 | -6.54% | 3 | Apr 1, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $6.26 | +187.54% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $35.15 | +42.25% | 2 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $0.69 | +1,052.74% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $51.74 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.05 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.08 | +428.85% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $75.83 | +45.06% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $0.85 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $5.74 | +5,126.48% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $7.98 | +250.88% | 1 | Aug 31, 2020 |
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $17.62
Upside: +24.86%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $158.36
Upside: -0.86%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $10.04
Upside: +69.32%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $41.74
Upside: +36.56%
Celcuity
May 16, 2024
Assumes: Buy
Price Target: $25 → $27
Current: $10.93
Upside: +147.03%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $21.44
Upside: -30.04%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $5.71
Upside: +40.11%
Accelerate Diagnostics
Apr 1, 2024
Maintains: Hold
Price Target: $2 → $1
Current: $1.07
Upside: -6.54%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $6.26
Upside: +187.54%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $35.15
Upside: +42.25%
May 12, 2023
Maintains: Buy
Price Target: $14 → $8
Current: $0.69
Upside: +1,052.74%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $51.74
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.05
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.08
Upside: +428.85%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $75.83
Upside: +45.06%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $0.85
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $5.74
Upside: +5,126.48%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $7.98
Upside: +250.88%